Simon Kiddle - October 9, 2024 Liquid precision bandages NoBACZ ingenious new gels create an instant seal over a wound. The company is changing the way farm ...
Joanna Smith - June 10, 2024 Mewburn Ellis ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent Practitioners 2024 We are delighted to once again be ranked ‘gold tier’ in IAM Patent 1000: The World’s Leading Patent ...
Simon Kiddle - January 2, 2024 The wonderful potential of waxworm saliva Enzymes are able to break up plastic, opening the way for rapid recycling.
Joanna Smith - July 4, 2023 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2023 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Simon Kiddle - November 16, 2022 Positive feedback on oral proceedings in oppositions carried out by videoconference In September, the EPO commissioned a survey about their opposition procedure, in particular asking ...
Jacqueline Murphy - July 4, 2022 Mewburn Ellis ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent Practitioners 2022 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Jacqueline Murphy - September 30, 2021 Mewburn Ellis: top tier firm Legal 500 2022 Mewburn Ellis is proud to be ranked top tier for our patent and trade mark practices in the 2022 ...
Robert Watson - July 2, 2021 Seeing Double at the EPO – what was G4/19 actually about? Whether double patenting, the granting of more than one patent for the same invention, should be ...
Jacqueline Murphy - July 2, 2021 IAM Patent 1000: The World’s Leading Patent Professionals 2021 We are delighted to once again be ranked ‘gold tier’ in IAM PATENT 1000: The World’s Leading Patent ...
Jacqueline Murphy - October 1, 2020 Mewburn Ellis: top tier firm Legal 500 2021 We are delighted to be ranked top tier for our patent practice in the 2021 edition of The Legal ...
Simon Kiddle - August 20, 2020 Oppositions & Appeals: we helped clear a new path to patenting dosage regimes Case 10 – T 1020/03 (EPO Board of Appeal, 29 October 2004)
Simon Kiddle - August 7, 2020 A shore thing: eco-friendly seaweed materials It may be a bother for sunbathers, but seaweed is a promising eco-friendly industrial material.
Seán Walton - July 24, 2020 Oppositions & Appeals: novelty of a patient sub-population Case 9 – T 734/12 (EPO Board of Appeal, 17 May 2013)
Simon Kiddle - June 29, 2020 Oppositions & Appeals: we helped determine the meaning of “surgery” Case 8 – T 1695/07 (EPO Board of Appeal, 28 September 2011)
Jacqueline Murphy - June 16, 2020 IAM Patent 1000: The World’s Leading Patent Professionals 2020 We are delighted to once again be ranked ‘highly recommended’ in ‘IAM 1000: The World’s Leading ...
Simon Kiddle - May 18, 2020 Oppositions & Appeals: We helped shape the debate on medical use claim patentability Case 7 – T 879/12 (EPO Board of Appeal, 27 August 2014)
Simon Kiddle - April 27, 2020 Oppositions & Appeals: We moved the conversation on animal involvement Case 6 – T 1262/04 (EPO Board of Appeal, 13 July 2012)
Seán Walton - March 12, 2020 Oppositions & Appeals: We set the standard for the strawman Case 5 - T 649/92 (EPO Enlarged Board of Appeal, 2 July 1996)
Simon Kiddle - January 29, 2020 Oppositions & Appeals: We made the case for a new technical effect Case 3 - T 1642/06 (EPO Board of Appeal, 23 August 2007)
Simon Kiddle - November 8, 2019 Meet The Team: Simon Kiddle, Partner, European Patent Attorney As part of our 'meet the team' series, we talk to Simon Kiddle about his journey to becoming a ...
Jacqueline Murphy - June 17, 2019 IAM Patent 1000, 2019 We are delighted to be ranked highly recommended in ‘IAM 1000: The World’s Leading Patent ...
Simon Kiddle - April 29, 2019 Personalised medicine: patient stratification While the general idea of customising treatment to patients is not new, the degree to which ...
Simon Kiddle - February 22, 2019 Is your interest legitimate? New referral to the EBOA on double patenting EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the ...
